Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Cyberonics board shuffle: Stockholders elect Houston investor Hugh Morrison as chairman and Alfred Novak, Arthur Rosenthal and Jeffrey Schwarz as new members of the board Feb. 1. Incumbent board chairman Tony Coelho and members Kevin Moore and Stanley Appel resign. Both the additions and the resignations were called for by the "Committee for Concerned Cyberonics, Inc. Shareholders" and hedge fund Metropolitan Capital Advisors, 7.33% shareholders of Cyberonics, in a heated proxy battle with Cyberonics' former board. Morrison has been on the Cyberonics board since November 2006 and served on the board of Advanced Neuromodulation Systems from 1983 until its sale to St. Jude Medical in 2005. Novak and Rosenthal have held executive positions at Cordis and Boston Scientific, respectively, and Schwarz has been CEO of Metropolitan Capital Advisors since 1992..

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel